This new technology is a next‑generation adaptation of Rekovar’s Neomonki wearable platform, designed to enable early detection of necrotizing enterocolitis (NEC) by integrating advanced biosensors, imaging analysis, and a newly developed AI‑driven clinical algorithm to continuously monitor physiologic and behavioral signals to identify early signs of NEC far earlier than current tools such as Bell’s criteria, blood tests, or radiologic studies.